Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Comparative Study of the Tomey FT-1000, and Goldmann Applanation Tonometer (GAT)

3 september 2026 uppdaterad av: Tomey Corporation

This study is intended to evaluate the agreement between Intraocular pressure(IOP) measurements obtained with the FT-1000 non-contact tonometer and a GAT to confirm the feasibility of the measurement procedures.

This is a prospective comparative study that will be conducted at one clinical site in the United States. Subjects who sign an informed consent form and fulfill all inclusion and exclusion criteria will undergo FT-1000 measurements followed by Goldmann applanation tonometry during a single study visit.

The primary analysis will be performed using one preselected study eye from each subject. Measurements from the fellow eye, when available, may be summarized as exploratory analyses but will not contribute to the primary effectiveness analysis.

In general, descriptive statistics (n, mean, standard deviation, median, minimum and maximum) will be used to summarize continuous variables. Frequencies and percentages will be used to summarize categorical variables. The number of accepted scans and the total number of scans evaluated will be summarized by scan type, device, and subject population.

Agreement between the FT-1000 and the Goldmann applanation tonometer will be evaluated using the study eye measurements by calculating the mean difference, standard deviation (SD), 95% limits of agreement (LOA), Bland-Altman plots, Deming regression, and Pearson correlation coefficient.

Exploratory analyses may also be performed using fellow-eye measurements.

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Studietyp

Observationell

Inskrivning (Beräknad)

30

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Ja

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Low Intraocular pressure(IOP) (22 years old or older) Middle Intraocular pressure(IOP)(22 years old or older) High Intraocular pressure(IOP)(22 years old or older)

Beskrivning

Inclusion Criteria:

  1. Male or female subjects 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed.
  2. Subjects who are able to understand and follow the study procedures and instructions provided by the clinical staff.
  3. Subjects who voluntarily provide written informed consent.
  4. Subjects who satisfy all study eligibility requirements and are able to undergo both FT-1000 and Goldmann applanation tonometry measurements during the study visit.

Exclusion Criteria:

  1. Subjects with only one functional eye.
  2. Subjects with poor or eccentric fixation in either eye.
  3. Subjects with a history of corneal surgery, including corneal laser or refractive surgery (e.g., LASIK).
  4. Subjects with corneal scarring, keratoconus, or any other clinically significant corneal pathology.
  5. Subjects with an active corneal or conjunctival infection or inflammation in either eye.
  6. Subjects with microphthalmos or buphthalmos.
  7. Subjects who are unable or unwilling to remove contact lenses before study measurements.
  8. Subjects with clinically significant dry eye disease that, in the investigator's opinion, may affect tonometry measurements.
  9. Subjects with blepharospasm (lid squeezing) or nystagmus that may interfere with accurate measurements.
  10. Subjects with abnormal central corneal thickness (CCT).
  11. Subjects with any condition or circumstance that, in the opinion of the investigator, could place the subject at significant risk, interfere with study participation, or confound interpretation of the study results.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
Low Intraocular pressure(IOP) Group: 7-16 mmHg
Group with IOP of 7-16 mmHg; 10 subjects.
Intraocular pressure measurement by non-contact tonometer and applanation tonometer.
Middle Intraocular pressure(IOP) Group: >16 to <23 mmHg
Group with IOP of >16 to <23 mmHg; 10 subjects.
Intraocular pressure measurement by non-contact tonometer and applanation tonometer.
High Intraocular pressure(IOP)Group: ≥23 mmHg
Group with IOP of ≥23 mmHg; 10 subjects.
Intraocular pressure measurement by non-contact tonometer and applanation tonometer.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Safety of the test devices
Tidsram: Through study completion, approximately 3 days
Any adverse events observed or reported during the study visit will be assessed and documented.
Through study completion, approximately 3 days
Agreement of the Intraocular pressure (IOP) mmHg between the test devices and predicate device
Tidsram: Through study completion, approximately 3 days

Agreement of the Intraocular pressure (IOP) mmHg between the FT-1000 and the Goldmann Applanation Tonometer(GAT) will be evaluated using the study eye measurements by calculating the mean difference, standard deviation (SD), 95% limits of agreement (LOA), Bland-Altman plots, Deming regression, and Pearson correlation coefficient.

Exploratory analyses may also be performed using fellow-eye measurements.

Through study completion, approximately 3 days

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

24 september 2026

Primärt slutförande (Beräknad)

28 september 2026

Avslutad studie (Beräknad)

28 september 2026

Studieregistreringsdatum

Först inskickad

31 augusti 2026

Först inskickad som uppfyllde QC-kriterierna

31 augusti 2026

Första postat (Faktisk)

4 september 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

9 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

3 september 2026

Senast verifierad

1 augusti 2026

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • TomeyFT-1000-001

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Ja

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera